{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T14:57:32Z","timestamp":1770821852478,"version":"3.50.1"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2015,7,10]],"date-time":"2015-07-10T00:00:00Z","timestamp":1436486400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0131994","type":"journal-article","created":{"date-parts":[[2015,7,10]],"date-time":"2015-07-10T14:08:21Z","timestamp":1436537301000},"page":"e0131994","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["Development of Nevirapine Resistance in Children Exposed to the Prevention of Mother-to-Child HIV-1 Transmission Programme in Maputo, Mozambique"],"prefix":"10.1371","volume":"10","author":[{"given":"Francisco","family":"Antunes","sequence":"first","affiliation":[]},{"given":"Pereira","family":"Zindoga","sequence":"additional","affiliation":[]},{"given":"Perp\u00e9tua","family":"Gomes","sequence":"additional","affiliation":[]},{"given":"Orvalho","family":"Augusto","sequence":"additional","affiliation":[]},{"given":"Isabel","family":"Mahumane","sequence":"additional","affiliation":[]},{"given":"Lu\u00eds","family":"Veloso","sequence":"additional","affiliation":[]},{"given":"Em\u00edlia","family":"Valadas","sequence":"additional","affiliation":[]},{"given":"Ricardo","family":"Camacho","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2015,7,10]]},"reference":[{"key":"ref1","unstructured":"UNAIDS. World AIDS Day Report\u20142011. Available: http:\/\/www.unaids.org\/en\/resources\/publications\/2011<\/ext-link>."},{"key":"ref2","unstructured":"UNAIDS. Outlook Report: 30 years into the AIDS epidemic. 2011. Available: http:\/\/www.unaids.org\/en\/resources\/publications\/2011<\/ext-link>"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa041305","article-title":"Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy","volume":"351","author":"G Jourdain","year":"2004","journal-title":"N Engl J Med"},{"key":"ref4","unstructured":"UNAIDS. UNAIDS Report On The Global AIDS Epidemic 2013. 2013. Available: http:\/\/www.unaids.org\/en\/resources\/documents\/2013\/20130923_UNAIDS_Global_R_eport_2013<\/ext-link>."},{"key":"ref5","unstructured":"UNAIDS. Global plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive 2011\u20132015. 2011. Available: http:\/\/www.unaids.org\/en\/resources\/documents\/2011<\/ext-link>."},{"key":"ref6","unstructured":"Whitson D, Horth R and Gon\u00e7alves S. Analysis of HIV prevention response and modes of HIV transmission: The UNAIDS-Gamet Supported Synthesis Process. 2008: 11\u20132. Available: http:\/\/www.unaidsrstesa.org\/resources\/reports\/analysis-hiv-prevention-response-and-modes-hiv-transmission-unaids-gamet-supported<\/ext-link>."},{"key":"ref7","unstructured":"MISAU. Boletim epidemiol\u00f3gico do Minist\u00e9rio da Sa\u00fade de Mo\u00e7ambique MISAU\u2014Resultados da ronda serologica. 2009. Available: http:\/\/www.misau.gov.mz\/index.php\/boletins-epidemiologicos<\/ext-link>"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0140-6736(99)07419-X","article-title":"Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial","volume":"354","author":"LA Guay","year":"1999","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1086\/367898","article-title":"A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1","volume":"187","author":"D Moodley","year":"2003","journal-title":"J Infect Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJMoa033500","article-title":"Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand","volume":"351","author":"M Lallemant","year":"2004","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/ije\/dym104","article-title":"Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: a meta-analysis","volume":"36","author":"E Arriv\u00e9","year":"2007","journal-title":"Int J Epidemiol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1056\/NEJMoa062876","article-title":"Response to antiretroviral therapy after a single, peripartum dose of nevirapine","volume":"356","author":"S Lockman","year":"2007","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1056\/NEJMoa1000931","article-title":"Antiretroviral treatment for children with peripartum nevirapine exposure","volume":"363","author":"P Palumbo","year":"2010","journal-title":"The N Engl Med"},{"key":"ref14","unstructured":"WHO. Rapid Advice: use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infant\u2014version 2. 2010."},{"key":"ref15","doi-asserted-by":"crossref","first-page":"e68213","DOI":"10.1371\/journal.pone.0068213","article-title":"Evolution of primary HIV drug resistance in a subtype C dominated epidemic in Mozambique","volume":"8","author":"DC Bila","year":"2013","journal-title":"PLoS One"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1128\/JCM.39.4.1254-1257.2001","article-title":"Performance of the applied biosystems ViroSeq human immunodeficiency virus type 1 (HIV-1) genotyping system for sequence-based analysis of HIV-1 in pediatric plasma samples","volume":"39","author":"S Cunningham","year":"2001","journal-title":"J Clin Microbiol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/nar\/gkg100","article-title":"Human immunodeficiency virus reverse transcriptase and protease sequence database","volume":"31","author":"SY Rhee","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1093\/bioinformatics\/bti607","article-title":"An automated genotyping system for analysis of HIV-1 and other microbial sequences","volume":"21","author":"T de Oliveira","year":"2005","journal-title":"Bioinformatics"},{"issue":"Suppl 2","key":"ref19","first-page":"83","article-title":"Surveillance of transmitted HIV drug resistance with the World Health Organization threshold survey method in Lilongwe, Malawi","volume":"13","author":"K Kamoto","year":"2008","journal-title":"Antivir Ther"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"5529","DOI":"10.1128\/AAC.00741-11","article-title":"Quantifying the impact of nevirapine-based prophylaxis strategies to prevent mother-to-child transmission of HIV-1: a combined pharmacokinetic, pharmacodynamic, and viral dynamic analysis to predict clinical outcomes","volume":"55","author":"M Frank","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/QAD.0b013e328344fedc","article-title":"Analysis of nevirapine resistance in HIV-infected infants who received extended nevirapine or nevirapine\/zidovudine prophylaxis","volume":"25","author":"J Fogel","year":"2011","journal-title":"AIDS"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1097\/QAD.0b013e3283492180","article-title":"HIV-1 drug resistance at antiretroviral treatment initiation in children previously exposed to single-dose nevirapine","volume":"25","author":"GM Hunt","year":"2011","journal-title":"AIDS"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1086\/652151","article-title":"Nevirapine resistance by timing of HIV type 1 infection in infants treated with single-dose nevirapine","volume":"50","author":"MA Micek","year":"2010","journal-title":"Clin Infect Dis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1097\/01.aids.0000194800.43799.94","article-title":"Resistance after single-dose nevirapine prophylaxis emerges in a high proportion of Malawian newborns","volume":"19","author":"SH Eshleman","year":"2005","journal-title":"AIDS"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1086\/430764","article-title":"Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVP","volume":"192","author":"SH Eshleman","year":"2005","journal-title":"J Infect Dis"},{"issue":"Suppl 4","key":"ref26","doi-asserted-by":"crossref","first-page":"S369","DOI":"10.1093\/cid\/cis006","article-title":"Surveillance of HIV drug resistance in children receiving antiretroviral therapy: a pilot study of the World Health Organization's generic protocol in Maputo, Mozambique","volume":"54","author":"P Vaz","year":"2012","journal-title":"Clin Infect Dis"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1093\/cid\/cis1219","article-title":"Greater suppression of nevirapine resistance with 21- vs 7-day antiretroviral regimens after intrapartum single-dose nevirapine for prevention of mother-to-child transmission of HIV","volume":"56","author":"DK McMahon","year":"2013","journal-title":"Clin Infect Dis"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1089\/aid.2007.0264","article-title":"Virologic and immunologic response to antiretroviral therapy and predictors of HIV type 1 drug resistance in children receiving treatment in Abidjan, Cote d'Ivoire","volume":"24","author":"C Adj\u00e9-Tour\u00e9","year":"2008","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/jpids\/pis065","article-title":"Nevirapine-resistant HIV-1 DNA in breast milk after single-dose nevirapine with or without zidovudine for prevention of mother-to-child transmission","volume":"1","author":"S Gantt","year":"2012","journal-title":"J Pediatric Infect Dis Soc"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/infdis\/jiu130","article-title":"Transmission of nevirapine-resistant HIV type 1 via breast milk to infants after single-dose nevirapine in Beira, Mozambique","volume":"4","author":"MA Micek","year":"2014","journal-title":"J Infect Dis"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1758-2652-14-30","article-title":"High prevalence of HIV-1 drug resistance among patients on first-line antiretroviral treatment in Lome, Togo","volume":"14","author":"AY Dagnra","year":"2011","journal-title":"J Int AIDS Soc"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/jac\/dku087","article-title":"HIV-1 drug mutations in children from northern Tanzania","volume":"7","author":"ER Shao","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"e283","DOI":"10.1097\/INF.0b013e3181ba6c92","article-title":"Risk of extended viral resistance in human immunodeficiency virus-1-infected Mozambican children after first-line treatment failure","volume":"28","author":"P Vaz","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1089\/aid.2012.0118","article-title":"Transmitted antiretroviral drug resistance in newly HIV-infected and untreated patients in Segou and Bamako, Mali","volume":"29","author":"AI Maiga","year":"2013","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1097\/00002030-200110190-00006","article-title":"Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012)","volume":"15","author":"SH Eshleman","year":"2001","journal-title":"AIDS"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1086\/430742","article-title":"Sensitive drug-resistance assays reveal long-term persistence of HIV-1 variants with the K103N nevirapine (NVP) resistance mutation in some women and infants after the administration of single-dose NVP: HIVNET 012","volume":"192","author":"T Flys","year":"2005","journal-title":"J Infect Dis"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/QAI.0b013e31802b920e","article-title":"Selection and persistence of viral resistance in HIV-infected children after exposure to single-dose nevirapine","volume":"44","author":"NA Martinson","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1086\/591503","article-title":"Analysis of nevirapine (NVP) resistance in Ugandan infants who were HIV infected despite receiving single-Dose (SD) NVP versus SD NVP plus daily NVP up to 6 weeks of age to prevent HIV vertical transmission","volume":"198","author":"JD Church","year":"2008","journal-title":"J Infect Dis"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"e4096","DOI":"10.1371\/journal.pone.0004096","article-title":"Nevirapine resistance and breast-milk HIV transmission: effects of single and extended-dose nevirapine prophylaxis in subtype C HIV-infected infants","volume":"4","author":"A Moorthy","year":"2009","journal-title":"PloS one"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/cid\/cir798","article-title":"A comparison of 3 regimens to prevent nevirapine resistance mutations in HIV-infected pregnant women receiving a single intrapartum dose of nevirapine","volume":"54","author":"RB Van Dyke","year":"2012","journal-title":"Clin Infect Dis"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0131994","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T05:34:17Z","timestamp":1540013657000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0131994"}},"subtitle":[],"editor":[{"given":"Soren","family":"Gantt","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2015,7,10]]},"references-count":40,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2015,7,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0131994","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,10]]}}}